The patient was described as confused and had ingested 182 tolterodine pills. Tolterodine prescribed for the patient was an immediate-release (IR), twice-daily, tablet formulation where each tablet contains 2mg of tolterodine tartrate. Patient had the following symptoms: “blood pressure at 175/80 mmHg, pulse rate at 82 beats per minute, Glasgow Coma Scale score was 13/15 (E4V4M5), body temperature was 38.3 degrees Celsius (tympanic), respiratory rate was 10 breaths per minute and oxygen saturation by pulse oximetry was 96% while he was put on oxygen through a non-rebreathing mask, chest auscultation was clear, abdominal examination revealed hypoactive bowel sound, pupils were 5 mm with sluggish response to light, palpation of the axillary skin showed it was dry, bedside glucose test was 6.8 mmol/L, electrocardiogram showed sinus rhythm, QTc by calculation using Bazett's formula was 462 ms, chest and abdominal X-rays were unremarkable, point-of-care tests of electrolytes and acid-base status were
The patient was described as confused and had ingested 182 tolterodine pills. Tolterodine prescribed for the patient was an immediate-release (IR), twice-daily, tablet formulation where each tablet contains 2mg of tolterodine tartrate. Patient had the following symptoms: “blood pressure at 175/80 mmHg, pulse rate at 82 beats per minute, Glasgow Coma Scale score was 13/15 (E4V4M5), body temperature was 38.3 degrees Celsius (tympanic), respiratory rate was 10 breaths per minute and oxygen saturation by pulse oximetry was 96% while he was put on oxygen through a non-rebreathing mask, chest auscultation was clear, abdominal examination revealed hypoactive bowel sound, pupils were 5 mm with sluggish response to light, palpation of the axillary skin showed it was dry, bedside glucose test was 6.8 mmol/L, electrocardiogram showed sinus rhythm, QTc by calculation using Bazett's formula was 462 ms, chest and abdominal X-rays were unremarkable, point-of-care tests of electrolytes and acid-base status were